DaVita Inc. $DVA Shares Sold by Applied Finance Capital Management LLC

Applied Finance Capital Management LLC cut its holdings in DaVita Inc. (NYSE:DVA) by 25.5% during the second quarter, Holdings Channel reports. The institutional investor owned 1,953 shares of the company’s stock after selling 670 shares during the quarter. Applied Finance Capital Management LLC’s holdings in DaVita were worth $278,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of DVA. National Pension Service grew its position in shares of DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after purchasing an additional 84 shares during the last quarter. Y.D. More Investments Ltd acquired a new stake in DaVita in the 1st quarter worth about $35,000. Ameritas Advisory Services LLC purchased a new stake in DaVita in the second quarter valued at approximately $47,000. NewEdge Advisors LLC grew its stake in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after buying an additional 88 shares during the period. Finally, University of Texas Texas AM Investment Management Co. acquired a new stake in shares of DaVita during the 1st quarter worth $83,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have issued reports on DVA. Weiss Ratings reissued a “hold (c+)” rating on shares of DaVita in a research report on Wednesday, October 8th. Bank of America decreased their target price on DaVita from $145.00 to $140.00 and set an “underperform” rating for the company in a report on Wednesday, September 10th. Truist Financial set a $140.00 price target on shares of DaVita in a report on Tuesday. Barclays decreased their price objective on shares of DaVita from $160.00 to $149.00 and set an “equal weight” rating for the company in a research note on Thursday, October 9th. Finally, Wall Street Zen lowered shares of DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $153.25.

DaVita Trading Up 0.4%

Shares of DVA stock opened at $125.79 on Friday. DaVita Inc. has a twelve month low of $122.93 and a twelve month high of $179.60. The company has a market capitalization of $8.99 billion, a PE ratio of 12.37, a price-to-earnings-growth ratio of 0.90 and a beta of 1.13. The firm has a fifty day simple moving average of $132.49 and a 200-day simple moving average of $138.31.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company’s revenue was up 6.1% on a year-over-year basis. During the same period last year, the firm earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Insider Buying and Selling

In other news, insider James O. Hearty sold 2,351 shares of the business’s stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares of the company’s stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is owned by company insiders.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.